MIC + L-Carnitine + B12 vs Retatrutide
A side-by-side research comparison of MIC + L-Carnitine + B12 and Retatrutide across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | MIC + L-Carnitine + B12 | Retatrutide |
|---|---|---|
| Full name | Lipotropic Injection Blend (Methionine, Inositol, Choline + L-Carnitine + B12) | Retatrutide (Triple Agonist GIP/GLP-1/Glucagon) |
| Category | Weight Management | Weight Management |
| Status | Compounded medication | Phase 3 Clinical Trial |
| Mechanism | Methionine aids fat breakdown and detoxification. Inositol helps redistribute body fat and improves insulin signaling. Choline prevents fat deposits in the liver. L-Carnitine shuttles fatty acids into mitochondria for oxidation. B12 supports energy metabolism and red blood cell formation. | Triple agonism creates synergistic metabolic effects. Glucagon activation increases energy expenditure and hepatic fat oxidation while GLP-1/GIP reduce appetite and improve insulin sensitivity. |
| Molecular weight | Blend (multiple active compounds) | 5,200 Da (approximate) |
| Half-life | Variable by component; B12 ~6 days, L-Carnitine ~17 hours | 6 days |
| Bioavailability | ~100% (intramuscular injection) | High (SubQ) |
| Typical dose | 1 mL injection (standardized blend) | 1-2 mg → titrate up to 12 mg |
| Frequency | 1-2x weekly | Once weekly |
| Route | Intramuscular injection | Subcutaneous injection |
MIC + L-Carnitine + B12 reported benefits
- Enhanced fat metabolism
- Increased energy levels
- Liver support and detoxification
- Improved mood and mental clarity
- Support for B12 deficiency
Retatrutide reported benefits
- Unprecedented weight loss (~24%)
- Significant liver fat reduction
- Improved cardiovascular markers
- Enhanced energy expenditure
- Superior glycemic control
Related comparisons
Research and educational reference only. Not medical advice.